2024-511814-20-00RecruitingPhase 1
A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
Source: EU CTIS (euclinicaltrials.eu) · Last updated 18 Sept 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- First submitted
- 19 Mar 2024
- Start date
- 10 Dec 2024
- Lead sponsor
- Tiumbio Co. Ltd.
- Diseases
- Haemophilia
- EU CT number
- 2024-511814-20-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 21
- 6 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult men with haemophilia A or B.
- Age
- 18 years or older
- Sex
- Men only
Read by machine on 9 Nov 2026.
Sites (6)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Specialized Hospital For Active Treatment Of Hematological Diseases EAD | Sofiya | Bulgaria | Recruiting |
| Hospital Universitario Regional de Málaga | Málaga | Spain | Recruiting |
| University Hospital Virgen Del Rocio S.L. | Sevilla | Spain | Recruiting |
| Hospital Universitario Y Politecnico La Fe | Valencia | Spain | Recruiting |
| Careggi University Hospital | Florence | Italy | Not yet recruiting |
| Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca | Cluj-Napoca | Romania | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.